<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01097811</url>
  </required_header>
  <id_info>
    <org_study_id>upeclin/HC/FMB-Unesp-41</org_study_id>
    <nct_id>NCT01097811</nct_id>
  </id_info>
  <brief_title>Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy</brief_title>
  <official_title>Erythromycin Versus Neomycin Treatment for Overt Hepatic Encephalopathy: a Double-blind, Randomised, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UPECLIN HC FM Botucatu Unesp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biophisics Department of Biosciences Institute - Unesp</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UPECLIN HC FM Botucatu Unesp</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison between the efficacy of two different antibiotics in patients with overt hepatic
      encephalopathy. The study is randomized, controlled and double-blinded.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2008</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery of hepatic encephalopathy</measure>
    <time_frame>three years</time_frame>
    <description>comparison of efficacy between two drugs for the treatment of hepatic encephalopathy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of hospitalization caused by hepatic encephalopathy</measure>
    <time_frame>three years</time_frame>
    <description>comparison of efficacy between two drugs for reducing the length of hospitalization during treatment of hepatic encephalopathy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Hepatic Encephalopathy</condition>
  <condition>Hypertension, Portal</condition>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Erythromycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Neomycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Erythromycin</intervention_name>
    <description>250 mg orally q.i.d.</description>
    <arm_group_label>Erythromycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neomycin</intervention_name>
    <description>1 g orally q.i.d.</description>
    <arm_group_label>Neomycin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hepatic cirrhosis or portal hypertension

          -  Hepatic Encephalopathy

        Exclusion Criteria:

          -  Acute liver failure

          -  Neuropsychiatric diseases

          -  Inflammatory bowel diseases

          -  Intestinal obstruction

          -  Shock

          -  Renal insufficiency

          -  Alcoholic hepatitis

          -  Alcohol abuse

          -  Antibiotic premedication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando G Romeiro</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina de Botucatu - UNESP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos A Caramori</last_name>
    <role>Study Chair</role>
    <affiliation>Faculdade de Medicina de Botucatu - UNESP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculdade de Medicina de Botucatu - Universidade Estadual Paulista</name>
      <address>
        <city>Botucatu</city>
        <state>São Paulo</state>
        <zip>18618970</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2010</study_first_submitted>
  <study_first_submitted_qc>March 31, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2010</study_first_posted>
  <last_update_submitted>April 27, 2010</last_update_submitted>
  <last_update_submitted_qc>April 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Fernando Gomes Romeiro / Doctor</name_title>
    <organization>Faculdade de Medicina de Botucatu - UNESP</organization>
  </responsible_party>
  <keyword>Hepatic Encephalopathy</keyword>
  <keyword>Hypertension, Portal</keyword>
  <keyword>Liver Cirrhosis</keyword>
  <keyword>Bacterial Overgrowth Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hepatic Encephalopathy</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erythromycin</mesh_term>
    <mesh_term>Erythromycin Estolate</mesh_term>
    <mesh_term>Erythromycin Ethylsuccinate</mesh_term>
    <mesh_term>Erythromycin stearate</mesh_term>
    <mesh_term>Neomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

